GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a prominent focus in therapeutic research, largely due to its impressive impact on controlling ailments such as second type diabetes and obesity. Ongoing research have demonstrated that beyond glucose management, GLP-1 drugs offer promise for heart function and possibly cogn